{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:42:39Z","timestamp":1780108959899,"version":"3.54.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jjcc.2020.10.015","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T04:54:44Z","timestamp":1604292884000},"page":"482-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis"],"prefix":"10.1016","volume":"77","author":[{"given":"Lu","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shandong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L","family":"Overton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipavan","family":"Chiamvimonvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phung N.","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2020.10.015_bib0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0010","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0025","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/Angiotensin 1\u20137 Axis of the renin\u2013Angiotensin system in heart failure","volume":"118","author":"Patel Vaibhav","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-2-19","article-title":"ACE2 gene expression is up-regulated in the human failing heart","volume":"2","author":"Goulter","year":"2004","journal-title":"BMC Med"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316668435","article-title":"Circulating ACE2 activity correlates with cardiovascular disease development","volume":"17","author":"\u00dari","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0040","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario Carlos","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0045","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0055","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2020.04.056","article-title":"Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission","author":"Roncon","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0070","article-title":"Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia","author":"Li","year":"2020","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0075","doi-asserted-by":"crossref","DOI":"10.1177\/1470320320926899","article-title":"Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression","volume":"21","author":"Pranata","year":"2020","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0080","first-page":"1","article-title":"COVID-19 and comorbidities: a systematic review and meta-analysis","author":"Gold","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0085","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0090","article-title":"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years","author":"Rentsch","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0095","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpaa096","article-title":"Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives","author":"Felice","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0100","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin\u2013Angiotensin\u2013Aldosterone system blockers and the risk of Covid-19","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0105","article-title":"Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study","author":"Regina","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0110","first-page":"e8069","article-title":"Nifedipine and amlodipine are associated with improved mortality and decreased risk for intubation and mechanical ventilation in elderly patients hospitalized for COVID-19","volume":"12","author":"Solaimanzadeh","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0115","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/00004872-200410000-00020","article-title":"Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation","volume":"22","author":"Campbell","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0125","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013Angiotensin\u2013Aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0130","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.dsx.2020.06.047","article-title":"The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"14","author":"Pranata","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0135","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2020-317336","article-title":"Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: a meta-analysis","author":"Flacco","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0140","article-title":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers","author":"Grover","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104927","article-title":"ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis","volume":"158","author":"Zhang","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.05.052","article-title":"Estimation of renin-angiotensin-Aldosterone-System (RAAS)-inhibitor effect on COVID-19 outcome: a meta-analysis","author":"Pirola","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0155","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/HYPERTENSIONAHA.120.15572","article-title":"Decreased mortality of COVID-19 with renin-angiotensin-Aldosterone system inhibitors therapy in patients with hypertension: a meta-analysis","volume":"76","author":"Guo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0160","first-page":"e10","article-title":"Renin-angiotensin-Aldosterone system inhibitors and outcome in patients with SARS-CoV-2 pneumonia: a case series study","volume":"76","author":"Andrea","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0165","article-title":"Assessment of clinical characteristics and mortality-associated factors in COVID-19 Critical cases in Kuwait","author":"Ayed","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0170","article-title":"ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS- COVID19 infection in a multi-site UK acute Hospital Trust","author":"Bean","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0175","article-title":"Predictors of severe or lethal COVID-19, including Angiotensin converting Enzyme Inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens","author":"Bravi","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0180","article-title":"Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health System","author":"Chang","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0185","article-title":"ARB\/ACEI use and severe COVID-19: a nationwide case-control study","author":"Choi","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study","author":"de Abajo","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0195","article-title":"The effects of ARBs, ACEIs and statins on clinical outcomes of COVID-19 infection among nursing home residents","author":"De Spiegeleer","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0200","article-title":"Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study","author":"Dublin","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0205","article-title":"Pre-existing traits associated with Covid-19 illness severity","author":"Ebinger","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0210","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1164\/rccm.202002-0445OC","article-title":"COVID-19 with different severities: a multicenter study of clinical features","volume":"201","author":"Feng","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0215","article-title":"The use of adjuvant therapy in preventing progression to severe pneumonia in patients with coronavirus disease 2019: a multicenter data analysis","author":"Feng","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0220","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.11301","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality","author":"Fosbol","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0225","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2020.06.013","article-title":"Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors","author":"Golpe","year":"2020","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0235","article-title":"Association of previous medications with the risk of COVID-19: a nationwide claims-based study from South Korea","author":"Huh","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0240","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13119","article-title":"Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States","author":"Imam","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0245","article-title":"Hypertension and renin-angiotensin-Aldosterone system inhibitors in patients with Covid-19","author":"Ip","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0250","article-title":"Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study","author":"Jung","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0255","article-title":"COVID-19 in Spain: age, Interleukin-6, C Reactive Protein and lymphocytes as key clues from a multicentre retrospective study","author":"Jurado","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0260","article-title":"Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study","author":"Khawaja","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0265","article-title":"Association of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with the risk of hospitalization and death in hypertensive patients with coronavirus Disease-19","author":"Khera","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0270","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0280","article-title":"Association between renin-angiotensin system inhibitors and COVID-19 complications","author":"Liabeuf","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0285","article-title":"Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients","author":"Liu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0290","article-title":"Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry","author":"Lopez-Otero","year":"2020","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0295","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0300","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0305","article-title":"Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study","author":"Morales","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0310","article-title":"Outcomes and cardiovascular comorbidities in a predominantly african-american population with COVID-19","author":"Nguyen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0315","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa677","article-title":"Long-term ACE Inhibitor\/ARB use is associated with severe renal dysfunction and acute kidney injury in patients with severe COVID-19: results from a referral center cohort in the North East of France","author":"Oussalah","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0320","article-title":"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York","author":"Palaiodimos","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0325","article-title":"NON-WHITE ethnicity, male sex, and higher body mass index, but not medications acting on the RENIN-ANGIOTENSIN system are associated with coronavirus disease 2019 (COVID-19) hospitalisation: review of the first 669 cases from the UK BIOBANK","author":"Raisi-Estabragh","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0330","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin\u2013Angiotensin\u2013Aldosterone system inhibitors and risk of Covid-19","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0335","article-title":"Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy","author":"Giorgi Rossi","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0340","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016948","article-title":"Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy","author":"Sardu","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0345","first-page":"21","article-title":"Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19","volume":"24","author":"Senkal","year":"2020","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0350","unstructured":"Tan N-D, Qiu Y, Xing X-B, Ghosh S, Chen M-H, Mao R. Associations between angiotensin converting enzyme inhibitors and angiotensin ii receptor blocker use, gastrointestinal symptoms, and mortality among Patients with COVID-19. Gastroenterology."},{"key":"10.1016\/j.jjcc.2020.10.015_bib0355","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa492","article-title":"Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19","author":"Tedeschi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0360","article-title":"Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility","author":"Trecarichi","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0365","article-title":"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China","author":"Yan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0370","unstructured":"Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J., et al. Effects of ARBs and ACEIs on virus infection, inflammatory status and clinical outcomes in COVID-19 patients with hypertension: a single center retrospective study. Hypertension. 0."},{"key":"10.1016\/j.jjcc.2020.10.015_bib0375","article-title":"Hypertension in patients hospitalized with COVID-19 in Wuhan, China: a single-center retrospective observational study","author":"Zeng","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0380","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin J-J, Xie J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation Research. 0."},{"key":"10.1016\/j.jjcc.2020.10.015_bib0385","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1161\/HYPERTENSIONAHA.120.15622","article-title":"Comparative impacts of ACE (Angiotensin-Converting enzyme) inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality","volume":"76","author":"Zhou","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0390","article-title":"Identifying main and interaction effects of risk factors to predict intensive care admission in patients hospitalized with COVID-19: a retrospective cohort study in Hong Kong","author":"Zhou","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jjcc.2020.10.015_bib0395","first-page":"1","article-title":"Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors","author":"Zhou","year":"2020","journal-title":"Clin Exp Hypertens"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508720303531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508720303531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:03:26Z","timestamp":1760274206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508720303531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0914508720303531"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2020.10.015","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2020.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}